What We Do

We develop software for use in hospital critical care medicine.  CIMVA™ software applications will provide physicians & nurses with actionable information about a patient’s health status in advance of current standard of care clinical indicators.  CIMVA’s value stems from its proprietary methods for enhanced analysis of a patient’s vital signs (heart rate, breathing rate, etc.) – providing information to physicians & nurses that is currently unavailable in the normal course of care in a hospital.  CIMVA analysis of vital signs results in treatment decisions that demonstrate the potential to both: (1) save lives and (2) reduce hospital costs.

CIMVA software is for use by physicians & nurses as they treat the patient; it is point-of-care clinical decision support used to enhance clinical judgement & experience.  CIMVA software analyzes vital sign data captured from patient monitors utilized in the hospital ICU and emergency department.  CIMVA’s web architecture enables flexible deployment that is readily displayed on both a PC work station or tablet device.

Currently critical care vital sign monitors offer only cursory analytical capability.  Monitors have little, if any, point-of-care clinical decision support for physicians & nurses to address important clinical problems so despite round-the-clock vital sign monitoring for the critically ill patient, hospitals still commonly resort to a “wait and see” approach to assess if a patient will improve or deteriorate or respond to therapeutic treatment.  This clinical uncertainty leads to thousands of unnecessary deaths annually, longer hospital stays and billions of dollars of avoidable cost in the health system (source: Johns Hopkins University School of Medicine).   A major unmet need exists for anticipatory monitoring, i.e. determining a patient’s health status in advance of clinical symptoms or as a prelude to a clinical intervention.   CIMVA software is being developed to meet this important goal.

The critical care hospital market is significant.  Annually in the United States over 4.6 million patients are treated in the ICU and over 1.4 million of these require use of a ventilator.   Millions of patients arrive at the ED and ICU with bacterial infection (termed sepsis) that in many instances is life threatening.